10.25384/SAGE.7011137.v1 Richard S Nicholas Richard S Nicholas Erika Han Erika Han Joel Raffel Joel Raffel Jeremy Chataway Jeremy Chataway Tim Friede Tim Friede MSJ794063_supplementary_material – Supplemental material for Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials SAGE Journals 2018 Progressive clinical trial multiple sclerosis 2018-08-24 12:00:00 Journal contribution https://sage.figshare.com/articles/journal_contribution/MSJ794063_supplementary_material_Supplemental_material_for_Over_three_decades_study_populations_in_progressive_multiple_sclerosis_have_become_older_and_more_disabled_but_have_lower_on-trial_progression_rates_A_systematic_review_and_meta-analysis_of_43_ran/7011137 <p>Supplemental material, MSJ794063_supplementary_material for Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials by Richard S Nicholas, Erika Han, Joel Raffel, Jeremy Chataway and Tim Friede in Multiple Sclerosis Journal</p>